Figures & data
Figure 1 Lemierre’s syndrome review: study inclusion and exclusion flow diagram.
Notes: Figure created using PRISMA 2009 flow diagram software from Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097 doi: 10.1371/journal.pmed.1000097. For more information, visit www.prisma-statement.org.Citation94
![Figure 1 Lemierre’s syndrome review: study inclusion and exclusion flow diagram.Notes: Figure created using PRISMA 2009 flow diagram software from Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097 doi: 10.1371/journal.pmed.1000097. For more information, visit www.prisma-statement.org.Citation94](/cms/asset/265d3816-2596-4517-95d2-5a23395222e9/didr_a_95050_f0001_c.jpg)
Table 1 Common clinical characteristics of Lemierre’s syndrome
Figure 2 Distribution of bacterial agent.
Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.
![Figure 2 Distribution of bacterial agent.Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.](/cms/asset/4685b5b9-18e3-4e0b-b95a-3bfad16abf81/didr_a_95050_f0002_c.jpg)